The prevalence, immunogenicity, and evanescence of alloantibodies to MUT and Mur antigens of GP.Mur red blood cells in a Southeast Asian patient cohort

Transfusion

Volumn 58, Issue 5, 2018, Pages 1189-1198

  Nadarajan, Veera Sekaran ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIGEN;

ASIAN CONTINENTAL ANCESTRY GROUP; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GENETICS; HUMAN; IMMUNOLOGY; PREVALENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GROUP ANTIGENS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; ISOANTIBODIES; PREVALENCE;

EID: 85056252240     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/TRF.14538     Document Type: Article

References (26)

1. Heathcote DJ, Carroll TE, Flower RL. Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned? Transfus Med Rev 2011;25:111-24.
2. Wei L, Shan ZG, Flower RL, et al. The distribution of MNS hybrid glycophorins with Mur antigen expression in Chinese donors including identification of a novel GYP.Bun allele. Vox Sang 2016;111:308-14.
3. Hsu K, Lin YC, Chao HP, et al. Assessing the frequencies of GP.Mur (Mi.III) in several Southeast Asian populations by PCR typing. Transfus Apher Sci 2013;49:370-1.
4. Prathiba R, Lopez CG, Usin FM. The prevalence of GP Mur and anti-“Mia” in a tertiary hospital in Peninsula Malaysia. Malays J Pathol 2002;24:95-8.
5. Nadarajan VS, Laing AA, Saad SM, et al. Prevalence and specificity of red-blood-cell antibodies in a multiethnic South and East Asian patient population and influence of using MUT1Mur1 kodecytes on its detection. Vox Sang 2012;102: 65-71.
6. Chen C, Tan J, Wang L, et al. Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review. Transfusion 2016;56:975-9.
7. Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia patients and literature review. Transfusion 2012;52:2220-4.
8. Mo Z, Li H, Huang L, et al. Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi. Transfus Med 2015;25:313-9.
9. Lin CK, Mak KH, Szeto SC, et al. First case of haemolytic disease of the newborn due to anti-Mur in Hong Kong. Clin Lab Haematol 1996;18:19-22.
10. Lin CK, Mak KH, Yuen CM, et al. A case of hydrops fetalis, probably due to antibodies directed against antigenic determinants of GP.Mur (Miltenberger class III) cells. Immunohematology 1996;12:115-8.
11. Heathcote D, Carroll T, Wang JJ, et al. Novel antibody screening cells, MUT1Mur kodecytes, created by attaching peptides onto red blood cells. Transfusion 2010;50: 635-41.
12. Schonewille H, van de, Loomans DS, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006;46:250-6.
13. Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009;49:505-12.
14. Musa RH, Ahmed SA, Hashim H, et al. Red cell phenotyping of blood from donors at the National blood center of Malaysia. Asian J Transfus Sci 2012;6:3-9.
15. Yu Y, Ma C, Sun X, et al. Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China. Int J Immunogenet 2016; 43:226-35.
16. R Development Core Team. R: a language and environment for statistical computing [Internet]. 2010. Available from https://cran.r-project.org/doc/manuals/r-release/fullrefman.pdf.
17. Therneau T. survival: survival analysis, including penalised likelihood. R package version 2.36-10. R package version 2.36-10 [Internet]. 2011. Available from: http://CRAN.R-pro-ject.org/package5survival.
18. Stack G, Tormey CA. Estimating the immunogenicity of blood group antigens: a modified calculation that corrects for transfusion exposures. Br J Haematol 2016;175:154-60.
19. Evers D, Middelburg RA, de Haas M, et al. Red-blood-cell alloimmunisation in relation to antigens’ exposure and their immunogenicity: a cohort study. Lancet Haematol 2016;3: e284-92.
20. Tormey CA, Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancyrelated antibodies. Blood 2009;114:4279-82.
21. Stack G, Tormey CA. Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence. Transfusion 2016;56:2662-7.
22. Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40:1127-31.
23. Yang CA, Lin JA, Chang CW, et al. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-“Mia” records decreases transfusion reaction rates in Taiwan. Transfus Med 2016;26:349-54.
24. a antigen. Vox Sang 2001;80: 230-3.
25. Giblett ER. A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961;1:233-8.
26. Winters JL, Pineda AA, Gorden LD, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001;41:1413-20.